Den procentvise median reduktion i antallet af inkontinensepisoder pr. uge i forhold til basisniveau var for både 7, 5 mg og 15 mg, ens for mænd og kvinder.
For both doses of 7.5 mg and 15 mg, the percentage median reduction from baseline in the number of incontinence episodes per week was similar between males and females.